Template:GC Conjunctivitis Treatment - Revision history

Danbot: Update Ceftriaxone dose for gonococcal conjunctivitis per CDC 2021 guidelines: 250mg → 1g IM

2026-03-20T11:35:13Z

Update Ceftriaxone dose for gonococcal conjunctivitis per CDC 2021 guidelines: 250mg → 1g IM

← Older revision		Revision as of 11:35, 20 March 2026
Line 7:		Line 7:
	====[[gonorrheal conjunctivitis\|Gonococcal]]====		====[[gonorrheal conjunctivitis\|Gonococcal]]====
	*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).		*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
	*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Ceftriaxone\|dose=~~250mg~~ IM ~~one~~ dose\|context=Gonococcal Conjunctivitis}} PLUS		*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Ceftriaxone\|dose=1g IM single dose\|context=Gonococcal Conjunctivitis}} PLUS
	*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Azithromycin\|dose=1g PO one dose\|context=Gonococcal Conjunctivitis}}		*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Azithromycin\|dose=1g PO one dose\|context=Gonococcal Conjunctivitis}}
	*'''Newborn Treatment:'''		*'''Newborn Treatment:'''

Danbot: Add disease=Gonorrheal conjunctivitis parameter to AntibioticDose calls - fixes aggregation page display issue

2026-03-19T23:12:30Z

Add disease=Gonorrheal conjunctivitis parameter to AntibioticDose calls - fixes aggregation page display issue

Danbot: Convert to {{AntibioticDose}} for SMW antibiotic-disease linking with Adult/Pediatric tracking

2026-03-19T22:45:22Z

Convert to {{AntibioticDose}} for SMW antibiotic-disease linking with Adult/Pediatric tracking

← Older revision		Revision as of 22:45, 19 March 2026
Line 1:		Line 1:
	====[[chlamydia conjunctivitis\|Chlamydial]]====		====[[chlamydia conjunctivitis\|Chlamydial]]====
	*[[Doxycycline]] 100mg PO BID for 7 days OR		*{{AntibioticDose\|drug=Doxycycline\|dose=100mg PO BID for 7 days\|context=Chlamydial Conjunctivitis}} OR
	*[[Azithromycin]] 1g (20mg/kg) PO one time dose		*{{AntibioticDose\|drug=Azithromycin\|dose=1g (20mg/kg) PO one time dose\|context=Chlamydial Conjunctivitis}}
	*'''Newborn Treatment:''' [[Azithromycin]] 20mg/kg PO once daily x 3 days or erythromycin PO 50 mg/kg/day in 4 divided doses for 14 days <ref>Zikic A, Schünemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e107-e115. doi: 10.1093/jpids/piy060. PMID: 30007329; PMCID: PMC6097578.</ref>		*'''Newborn Treatment:''' {{AntibioticDose\|drug=Azithromycin\|dose=20mg/kg PO once daily x 3 days\|context=Chlamydial Conjunctivitis, Newborn\|population=Pediatric}} or erythromycin PO 50 mg/kg/day in 4 divided doses for 14 days <ref>Zikic A, Schünemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e107-e115. doi: 10.1093/jpids/piy060. PMID: 30007329; PMCID: PMC6097578.</ref>
	**Disease manifests 5 days post-birth to 2 weeks (late onset)		**Disease manifests 5 days post-birth to 2 weeks (late onset)

	====[[gonorrheal conjunctivitis\|Gonococcal]]====		====[[gonorrheal conjunctivitis\|Gonococcal]]====
	*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).		*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
	*[[Ceftriaxone]] 250mg IM one dose PLUS		*{{AntibioticDose\|drug=Ceftriaxone\|dose=250mg IM one dose\|context=Gonococcal Conjunctivitis}} PLUS
	*[[Azithromycin]] 1g PO one dose		*{{AntibioticDose\|drug=Azithromycin\|dose=1g PO one dose\|context=Gonococcal Conjunctivitis}}
	*'''Newborn Treatment:'''		*'''Newborn Treatment:'''
	**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1		**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1
	**Disease manifests 1st 5 days post delivery (early onset)		**Disease manifests 1st 5 days post delivery (early onset)
	**Treatment [[Ceftriaxone]] 25-50mg IV or IM, max 125mg or cefotaxime single dose of 100 mg/kg (preferred if the patient has hyperbilirubinemia)		**Treatment {{AntibioticDose\|drug=Ceftriaxone\|dose=25-50mg IV or IM, max 125mg\|context=Gonococcal Conjunctivitis, Newborn\|population=Pediatric}} or cefotaxime single dose of 100 mg/kg (preferred if the patient has hyperbilirubinemia)
	**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)		**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)

Cmb23: /* Gonococcal */

2023-10-21T21:41:11Z

Gonococcal

← Older revision		Revision as of 21:41, 21 October 2023
Line 12:		Line 12:
	**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1		**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1
	**Disease manifests 1st 5 days post delivery (early onset)		**Disease manifests 1st 5 days post delivery (early onset)
	**Treatment [[Ceftriaxone]] 25-50mg IV or IM, max 125mg or cefotaxime single dose of 100 mg/kg		**Treatment [[Ceftriaxone]] 25-50mg IV or IM, max 125mg or cefotaxime single dose of 100 mg/kg (preferred if the patient has hyperbilirubinemia)
	**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)		**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)

Cmb23: /* Gonococcal */

2023-10-21T21:36:58Z

Gonococcal

← Older revision		Revision as of 21:36, 21 October 2023
Line 12:		Line 12:
	**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1		**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1
	**Disease manifests 1st 5 days post delivery (early onset)		**Disease manifests 1st 5 days post delivery (early onset)
	**Treatment [[Ceftriaxone]] 25-50mg IV or IM, max 125mg		**Treatment [[Ceftriaxone]] 25-50mg IV or IM, max 125mg or cefotaxime single dose of 100 mg/kg
			**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)

Cmb23: /* Chlamydial */

2023-10-21T21:32:18Z

Chlamydial

← Older revision		Revision as of 21:32, 21 October 2023
Line 2:		Line 2:
	*[[Doxycycline]] 100mg PO BID for 7 days OR		*[[Doxycycline]] 100mg PO BID for 7 days OR
	*[[Azithromycin]] 1g (20mg/kg) PO one time dose		*[[Azithromycin]] 1g (20mg/kg) PO one time dose
	*'''Newborn Treatment:''' [[Azithromycin]] 20mg/kg PO once daily x 3 days		*'''Newborn Treatment:''' [[Azithromycin]] 20mg/kg PO once daily x 3 days or erythromycin PO 50 mg/kg/day in 4 divided doses for 14 days <ref>Zikic A, Schünemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e107-e115. doi: 10.1093/jpids/piy060. PMID: 30007329; PMCID: PMC6097578.</ref>
	**Disease manifests 5 days post-birth to 2 weeks (late onset)		**Disease manifests 5 days post-birth to 2 weeks (late onset)

Cfricano: /* Gonococcal */

2019-11-16T05:42:08Z

Gonococcal

← Older revision		Revision as of 05:42, 16 November 2019
Line 7:		Line 7:
	====[[gonorrheal conjunctivitis\|Gonococcal]]====		====[[gonorrheal conjunctivitis\|Gonococcal]]====
	*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).		*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
	*[[Ceftriaxone]] 1g IM one dose PLUS		*[[Ceftriaxone]] 250mg IM one dose PLUS
	*[[Azithromycin]] 1g PO one dose		*[[Azithromycin]] 1g PO one dose
	*'''Newborn Treatment:'''		*'''Newborn Treatment:'''

ClaireLewis at 16:27, 5 October 2019

2019-10-05T16:27:43Z

← Older revision		Revision as of 16:27, 5 October 2019
Line 1:		Line 1:
	====Chlamydial====		====[[chlamydia conjunctivitis\|Chlamydial]]====
	*[[Doxycycline]] 100mg PO BID for 7 days OR		*[[Doxycycline]] 100mg PO BID for 7 days OR
	*[[Azithromycin]] 1g (20mg/kg) PO one time dose		*[[Azithromycin]] 1g (20mg/kg) PO one time dose
Line 5:		Line 5:
	**Disease manifests 5 days post-birth to 2 weeks (late onset)		**Disease manifests 5 days post-birth to 2 weeks (late onset)

	====Gonococcal====		====[[gonorrheal conjunctivitis\|Gonococcal]]====
	*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).		*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
	*[[Ceftriaxone]] 1g IM one dose PLUS		*[[Ceftriaxone]] 1g IM one dose PLUS

Lisayee25: /* Gonococcal */

2019-09-03T18:01:41Z

Gonococcal

← Older revision		Revision as of 18:01, 3 September 2019
Line 6:		Line 6:

	====Gonococcal====		====Gonococcal====
	*~~Dual treatment~~ for [[Chlamydia~~]] is recommended with azithromycin~~		*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
	*[[Ceftriaxone]] 1g IM one dose PLUS		*[[Ceftriaxone]] 1g IM one dose PLUS
	*[[Azithromycin]] 1g PO one dose		*[[Azithromycin]] 1g PO one dose

Gheid: /* Chlamydial */

2019-06-23T13:34:00Z

Chlamydial

← Older revision		Revision as of 13:34, 23 June 2019
Line 1:		Line 1:
	====Chlamydial====		====Chlamydial====
	*[[Doxycycline]] 100mg BID for 7 days OR		*[[Doxycycline]] 100mg PO BID for 7 days OR
	*[[Azithromycin]] 1g (20mg/kg) PO one time dose		*[[Azithromycin]] 1g (20mg/kg) PO one time dose
	*'''Newborn Treatment:''' [[Azithromycin]] 20mg/kg PO once daily x 3 days		*'''Newborn Treatment:''' [[Azithromycin]] 20mg/kg PO once daily x 3 days

← Older revision		Revision as of 23:12, 19 March 2026
Line 1:		Line 1:
	====[[chlamydia conjunctivitis\|Chlamydial]]====		====[[chlamydia conjunctivitis\|Chlamydial]]====
	*{{AntibioticDose\|drug=Doxycycline\|dose=100mg PO BID for 7 days\|context=Chlamydial Conjunctivitis}} OR		*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Doxycycline\|dose=100mg PO BID for 7 days\|context=Chlamydial Conjunctivitis}} OR
	*{{AntibioticDose\|drug=Azithromycin\|dose=1g (20mg/kg) PO one time dose\|context=Chlamydial Conjunctivitis}}		*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Azithromycin\|dose=1g (20mg/kg) PO one time dose\|context=Chlamydial Conjunctivitis}}
	*'''Newborn Treatment:''' {{AntibioticDose\|drug=Azithromycin\|dose=20mg/kg PO once daily x 3 days\|context=Chlamydial Conjunctivitis, Newborn\|population=Pediatric}} or erythromycin PO 50 mg/kg/day in 4 divided doses for 14 days <ref>Zikic A, Schünemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e107-e115. doi: 10.1093/jpids/piy060. PMID: 30007329; PMCID: PMC6097578.</ref>		*'''Newborn Treatment:''' {{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Azithromycin\|dose=20mg/kg PO once daily x 3 days\|context=Chlamydial Conjunctivitis, Newborn\|population=Pediatric}} or erythromycin PO 50 mg/kg/day in 4 divided doses for 14 days <ref>Zikic A, Schünemann H, Wi T, Lincetto O, Broutet N, Santesso N. Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e107-e115. doi: 10.1093/jpids/piy060. PMID: 30007329; PMCID: PMC6097578.</ref>
	**Disease manifests 5 days post-birth to 2 weeks (late onset)		**Disease manifests 5 days post-birth to 2 weeks (late onset)

	====[[gonorrheal conjunctivitis\|Gonococcal]]====		====[[gonorrheal conjunctivitis\|Gonococcal]]====
	*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).		*Due to increasing resistance, CDC recommends dual therapy with Ceftriaxone and Azithromycin (even if patient is negative for Chlamydia).
	*{{AntibioticDose\|drug=Ceftriaxone\|dose=250mg IM one dose\|context=Gonococcal Conjunctivitis}} PLUS		*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Ceftriaxone\|dose=250mg IM one dose\|context=Gonococcal Conjunctivitis}} PLUS
	*{{AntibioticDose\|drug=Azithromycin\|dose=1g PO one dose\|context=Gonococcal Conjunctivitis}}		*{{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Azithromycin\|dose=1g PO one dose\|context=Gonococcal Conjunctivitis}}
	*'''Newborn Treatment:'''		*'''Newborn Treatment:'''
	**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1		**Prophylaxis: [[Erythromycin]] ophthalmic 0.5% x1
	**Disease manifests 1st 5 days post delivery (early onset)		**Disease manifests 1st 5 days post delivery (early onset)
	**Treatment {{AntibioticDose\|drug=Ceftriaxone\|dose=25-50mg IV or IM, max 125mg\|context=Gonococcal Conjunctivitis, Newborn\|population=Pediatric}} or cefotaxime single dose of 100 mg/kg (preferred if the patient has hyperbilirubinemia)		**Treatment {{AntibioticDose\|disease=Gonorrheal conjunctivitis\|drug=Ceftriaxone\|dose=25-50mg IV or IM, max 125mg\|context=Gonococcal Conjunctivitis, Newborn\|population=Pediatric}} or cefotaxime single dose of 100 mg/kg (preferred if the patient has hyperbilirubinemia)
	**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)		**Also requires evaluation for disseminated disease (meningitis, arthritis, etc.)